Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) International Meeting 2018, the first of its kind, was held in Barcelona, Spain, from 25–27 October.

Explore the latest CLL news with meeting highlights from the speakers themselves, including biomarkers, opinion on MRD, epigenetics and data to watch out for at ASH 2018.

ERIC 2018

25–27 October 2018 | Barcelona, Spain

ERIC 2018

25–27 October 2018 | Barcelona, Spain

The European Research Initiative on Chronic Lymphocytic Leukemia (ERIC) International Meeting 2018, the first of its kind, was held in Barcelona, Spain, from 25–27 October.

Explore the latest CLL news with meeting highlights from the speakers themselves, including biomarkers, opinion on MRD, epigenetics and data to watch out for at ASH 2018.

Immune exhaustion in CLL 0:58
Immune exhaustion in CLL
Adrian Wiestner • 25 Oct 2018
Microenvironmental interactions and signaling pathways in CLL 1:05
Microenvironmental interactions and signaling pathways in CLL
Silvia Deaglio • 25 Oct 2018
Regulation of MRD in CLL: FDA and EMA 1:03
Regulation of MRD in CLL: FDA and EMA
Peter Hillmen • 25 Oct 2018
Cellular therapies in CLL: from transplant to CAR T-cells? 2:11
Cellular therapies in CLL: from transplant to CAR T-cells?
Jennifer Brown • 25 Oct 2018
Considerations in CLL with new treatments 3:10
Considerations in CLL with new treatments
Florence Cymbalista • 25 Oct 2018
A perspective on the current landscape of CLL treatment 2:11
A perspective on the current landscape of CLL treatment
Eva Kimby • 25 Oct 2018
CLL progress: a brief history 2:05
CLL progress: a brief history
Emili Montserrat • 25 Oct 2018
UK-based CLL clinical trials to look forward to 2:21
UK-based CLL clinical trials to look forward to
Daniel Catovsky • 25 Oct 2018
Pre-leukemic state and CLL show similar genomic landscapes: what does this tell us? 1:27
Pre-leukemic state and CLL show similar genomic landscapes: what does this tell us?
Andreas Agathangelidis • 25 Oct 2018
Tailoring treatment in CLL using predictive markers 2:29
Tailoring treatment in CLL using predictive markers
Alessandra Tedeschi • 25 Oct 2018
The first ERIC International Meeting: advancing the CLL field 1:04
The first ERIC International Meeting: advancing the CLL field
Emili Montserrat • 25 Oct 2018
Novel ventoclax combinations for CLL 1:09
Novel ventoclax combinations for CLL
Eva Kimby • 25 Oct 2018
Thoughts on the use of MRD in CLL 1:16
Thoughts on the use of MRD in CLL
Daniel Catovsky • 25 Oct 2018
Personalizing CLL treatment: MRD-guided therapy? 1:15
Personalizing CLL treatment: MRD-guided therapy?
Alessandra Tedeschi • 25 Oct 2018
Bispecific antibody response boosting with ibrutinib for CLL 2:03
Bispecific antibody response boosting with ibrutinib for CLL
Adrian Wiestner • 25 Oct 2018
The CLL epigenome 1:23
The CLL epigenome
Elias Campo • 25 Oct 2018
The content of VJHemOnc is intended for healthcare professionals